Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 2 (2012) CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... gout the composition of fatty acids in erythrocyte membranes lipids changed due to increase ..."
 
Vol 7, No 5 (2011) DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina
"... The world publications data about the impact of consumption and the fatty acids ratio in consumed ..."
 
Vol 9, No 1 (2013) THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS Abstract  similar documents
A. O. Malygin, V. L. Doshchitsin
"... Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic ..."
 
Vol 8, No 1 (2012) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids ..."
 
Vol 11, No 3 (2015) OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... Efficacy of omega-3 fatty acids in cardiology is so high that in many countries omega-3 fatty ..."
 
Vol 8, No 3 (2012) THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN Abstract  similar documents
O. V. Baturina, S. R. Gilyarevsky, I. M. Kuzmina, M. A. Godkov, E. V. Klychnikova
"... Aim. To evaluate the diagnostic value of heart-type fatty acid-binding protein (H-FABP ..."
 
Vol 7, No 1 (2011) USE OF N-3 POLYUNSATURATED FATTY ACIDS 90% (OMACOR) FOR THERAPY AND PREVENTION OF CARDIO-VASCULAR DISEASES  similar documents
"... ПОЛИНЕНАСЫЩЕННЫХ ЖИРНЫХ КИСЛОТ 90% (ОМАКОР) ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ Сердечно ..."
 
Vol 4, No 3 (2008) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION Abstract  similar documents
A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk
"... Aim. To estimate an efficacy of therapy with ω-3 polyunsaturated fatty acids (PUFA) in patients ..."
 
Vol 2, No 3 (2006) NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION Abstract  similar documents
A. I. Martinov, V. L. Chomenko
"... fatty acids (PUFAs) were analyzed. It was proved that PUFAs class omega-3 have positive effects ..."
 
Vol 8, No 2 (2012) THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
"... A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally ..."
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
"... polyunsaturated fatty acid can be used in the dosage of 2-4 g daily. In patients with triglyceride level higher ..."
 
Vol 7, No 2 (2011) EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY Abstract  similar documents
S. Nodari, M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M. Cesana, M. Gheorghiade, L. Dei Cas
"... Цель. Оценить влияния n-3 полиненасыщенных жирных кислот (ПНЖК) на систолическую функцию левого ..."
 
Vol 9, No 3 (2013) PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY Abstract  similar documents
S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik
"... Disorders of intermediary metabolism in the glycolysis cycles and fatty acids oxidation play ..."
 
Vol 7, No 2 (2011) COMMENTS TO THE PAPER S. NODARI ET AL. «EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY»  similar documents
S. N. Tereshchenko
"... МГМСУ КОММЕНТАРИЙ К СТАТЬЕ S. Nodari и соавт. «Влияние n-3 полиненасыщенных жирных кислот на функцию ..."
 
Vol 7, No 4 (2011) EXPERT CONSENSUS ON ETHYL ETHER OF ω-3 POLYUNSATURATED FATTY ACIDS 90% FOR THERAPY AND PREVENTION OF CHRONIC HEART FAILURE EXECUTIVE SUMMARY OF EXPERT COUNCIL, JUNE 2011  similar documents
"... ПОЛИНЕНАСЫЩЕННЫХ ЖИРНЫХ КИСЛОТ 90% ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ (ЗАКЛЮЧЕНИЕ ..."
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... (CVD) in patients with gout depending on the presence of MS. Material and methods. 56 patients (aged ..."
 
Vol 9, No 5 (2013) CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... include ω-3 polyunsaturated fatty acids, angiotensin receptor antagonists should be used ..."
 
Vol 12, No 4 (2016) Renal filtration function in patients with gout Abstract  similar documents
N. N. Kushnarenko, T. A. Medvedeva, A. V. Govorin, M. Yu. Mishko
"... Aim. To study circadian blood pressure (BP) profile in patients with gout depending ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... - зываясь с рецепторами к тромбоксану [34]. Резолвины, метаболиты омега-3-полиненасыщенных жирных кислот ..."
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... An experience of acetylsalicylic acid (ASA) clinical use since its synthesis in 1887 ..."
 
Vol 7, No 3 (2011) VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY Abstract  similar documents
E. P. Trukhacheva, M. V. Ezhov
"... acid intake in these patients may be necessary for the normalization of lipid profile, including ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... and nonalcoholic fatty liver disease (NAFLD) or other hepatobiliary diseases, especially in cases when elevated ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... The problem of non-alcoholic fatty liver disease (NAFLD), which is an independent risk factor ..."
 
Vol 7, No 4 (2011) COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) Abstract  similar documents
O. V. Dralova, M. L. Maksimov
"... Pharmacotherapy optimization in patients with arterial hypertension and gout is very important ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... Orotic acid is one of the intermediates in the pyrimidine biosynthesis. Mechanisms of physiological ..."
 
Vol 8, No 1 (2012) NEW POSSIBILITIES IN HEART FAILURE THERAPY: POTENTIAL OF DRUGS BASED ON URSODEOXYCHOLIC ACID Abstract  similar documents
O. M. Drapkina, O. N. Korneyeva
"... функции эндотелия у больных ХСН. Пре- параты урсодеоксихолевой кислоты (УДХК), приме- няемые при ..."
 
Vol 8, No 2 (2012) ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS Abstract  similar documents
A. V. Govorin, A. P. Filev
"... of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..."
 
Vol 9, No 4 (2013) ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES Abstract  similar documents
E. N. Dankovtseva
"... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention ..."
 
Vol 10, No 2 (2014) HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY) Abstract  similar documents
S. A. Shalnova, A. D. Deev, G. V. Artamonov, D. V. Duplyakov, A. Yu. Efanov, Yu. V. Zhernakova, A. O. Konradi, R. A. Libis, G. A. Muromtseva, S. V. Nedogoda, E. V. Oschepkova, S. V. Romanchuk, O. P. Rotar, V. N. Titov, Z. A. Toguzova, I. A. Trubacheva, G. I. Furmenko, E. V. Shlyakhto, S. A. Boytsov
"... этих регионах существует наименьшая  распространенность  повышенного уровня мочевой кислоты ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA ..."
 
Vol 8, No 4 (2012) UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Abstract  similar documents
E. A. Protasova, N. V. Furman, O. V. Reshet'ko
"... polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent ..."
 
Vol 8, No 4 (2012) ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? Abstract  similar documents
I. V. Zhirov
"... The results of recent trials on acetylsalicylic acid (ASA) efficacy are presented. Data ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... Data about efficacy and safety of long-term therapy with acetylsalicylic acid in patients ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... and ursodeoxycholic acid; 4) view of the inadmissibility of statin use in patients with transaminase levels more than ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... Aim. To assess the potential of ursodeoxycholic acid (UDCA) in the prevention of liver dysfunction ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... Use of acetylsalicylic acid (ASA) in cardiology practice is presented. ASA modes of action ..."
 
Vol 14, No 4 (2018) Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome Abstract  similar documents
O. M. Drapkina, O. E. Shirobokikh
"... many pathways including trimethylamine-N-oxide pathway (TMAO), short-chain fatty acids and second bile ..."
 
Vol 11, No 1 (2015) MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT Abstract  similar documents
O. M. Drapkina, E. M. Chernova
"... : fatty acid oxidation disorders, mitochondrial dysfunction, increased protein degradation in myocytes due ..."
 
Vol 15, No 2 (2019) Ventricular Tachycardia Induced by Exercise Test as a Predictor of Coronary Artery Disease Development Abstract  similar documents
A. A. Tatarinova, E. A. Ryngach, T. V. Treshkur, D. V. Ryzhkova, O. N. Zhdanova, D. V. Svalov
"... with fatty acids revealed the ischemic genesis of arrhythmias, which was indirectly confirmed by a positive ..."
 
Vol 11, No 5 (2015) The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis Abstract  similar documents
S. A. Smetnev, A. N. Meshkov
"... окисле- ние жирных кислот. Адипонектин секретируется ади- поцитами, главным образом, висцеральной области ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... Aim. To evaluate the differences between a group of patients treated with ursodeoxycholic acid ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
"... Lesion of gastrointestinal mucous coat is the main factor limited acetylsalicylic acid (ASA) use ..."
 
Vol 8, No 3 (2012) MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... intracellular penetration. Magnerot deserves attention as a complex drug consisting of magnesium and orotic acid ..."
 
Vol 2, No 1 (2006) THE USE OF A NEW APPROACH TO PREVENTION AND THERAPY OF ACUTE ARTERIAL HYPERTENSION WITH COMPLEX OF WELL-KNOWN DRUGS WITH VEGETABLE GLYCOSIDES (EXPERIMENTAL STUDY) Abstract  similar documents
T. G. Tolstikova, I. V. Sorokina, A. O. Brisgalov, M. P. Dolgich, G. I. Lifshitz, M. V. Chvostov
"... short acting formulation while NC is a new formulation of nifedipine in complex with glycyrrhizic acid ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... Aim. To compare antiplatelet effect of two acetylsalicylic acid medicines, Acecardol ("Synthesis ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE Abstract  similar documents
V. N. Drozdov, V. A. Kim
"... Data about efficacy and safety of acetylsalicylic acid usage as antiplatelet drug and for cancer ..."
 
Vol 7, No 4 (2011) FOCUS ON MAGNESIUM BASED DRUGS Abstract  similar documents
I. I. Esenova
"... deficiency, advantages of magnesium salts of orotic acid are reviewed. ..."
 
Vol 8, No 1 (2012) URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL  similar documents
S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker
"... Цель. Оценить влияние урсодеоксихолевой кислоты (УДХК) на функцию эндотелия и маркеры воспаления у ..."
 
Vol 3, No 4 (2007) RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
"... sensitivity to acetylsalicylic acids (ASA) in patients with stable angina. Material and methods. 96 patients ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... Background. Vitamins В6 В12 and folic acid (FA) therapy to reduce cardiovascular risk appears ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..."
 
Vol 7, No 2 (2011) PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? Abstract  similar documents
I. V. Zotova, D. A. Zateyshchikov
"... ацетилсалициловой кислоты (АСК) сопро- вождается снижением риска развития ССО. В крупном проспективном ..."
 
Vol 12, No 3 (2016) MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES Abstract  PDF (Eng)  similar documents
O. M. Drapkina, E. I. Fomicheva
"... TGR5 are G-protein-linked, membrane bile acids receptors that widely express in tissues of animals ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... and morphology of erythrocytes and to assess their changes during therapy with acetylsalicylic emacid/em, clopidogrel ..."
 
Vol 15, No 2 (2019) Association between Sympathetic Nervous System Activation, Obesity and Insulin Resistance Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova, A. V. Starodubova, Т. М. Оstroumova, D. A. Bondarenko
"... , hyperleptinemia, the effect of nonesterified emfatty/em emacids/em, obstructive sleep apnea and baroreflex impairment ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... emfatty/em liver disease, viral hepatitis C are considered separately. ..."
 
Vol 14, No 3 (2018) THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova
"... are presented. Current data on the pattern of antiplatelet use, including acetylsalicylic emacid/em, in individuals ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... Aim. To study a rate of resistance to acetylsalicylic emacid/em (ASA) and clopidogrel and clinical ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... Aim. To evaluate the incidence of acetylsalicylic emacid/em (ASA) and clopidogrel resistance ..."
 
Vol 12, No 3 (2016) CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY Abstract  PDF (Eng)  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko
"... that are sensitive or resistant to acetylsalicylic emacid/em (ASA) before and after coronary artery bypass graft (CABG ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... K antagonists (such as warfarin), antiplatelet therapy (such as acetylsalicylic emacid/em) and novel oral ..."
 
Vol 5, No 6 (2009) RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID Abstract  similar documents
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
"... to acetylsalicylic emacid/em (ASA) therapy. Material and methods. 200 patients with ACS (aged 56,6±9,2 y.o.) were ..."
 
Vol 13, No 2 (2017) RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY Abstract  similar documents
. Editorial
"... эффективность и безопасность ривароксабана в дозах 20 мг 1 р/д*, 10 мг 1 р/д и ацетилсалициловой emкислоты/em в дозе ..."
 
Vol 6, No 3 (2010) CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
V. N. Larina, B. Ya. Bart, V. G. Larin
"... , vitamin B12 or folic emacid/em was a reason of anemia in 35,8%, 9,4% and 15,1% of patients, respectively ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... of action and clinical efficiency of antithrombotic and antiplatelet medicines such as acetylsalicylic emacid/em ..."
 
Vol 15, No 3 (2019) Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery Abstract  similar documents
A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein
"... with acetylsalicylic emacid/em (ASA) resistance in patients with coronary heart disease after coronary bypass surgery (CABG ..."
 
Vol 15, No 3 (2019) Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities Abstract  similar documents
article Editorial
"... and acetylsalicylic emacid/em can be recommended after registration of the indication for almost all patients ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... . Along with traditional drugs (acetylsalicylic emacid/em, warfarin) rivaroxaban is specially considered ..."
 
Vol 7, No 4 (2011) PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. L. Komarov, O. O. Shahmatova, D. V. Rebrikov, D. Yu. Trophimov, T. I. Kotkina, T. A. Ilyushenko, A. D. Deev, E. P. Panchenko
"... и 1298 AА проявлялось при условии сопутствующего снижения уровня фолиевой emкислоты/em плазмы крови ..."
 
Vol 9, No 5 (2013) ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE Abstract  similar documents
L. N. Maksimova, M. L. Maksimov, Y. R. Nartsissov, R. M. Zaslavskaya, E. V. Kalinina
"... Questions of metabolite therapy with drugs based on glutamic emacid/em in patients with chronic heart ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... (warfarin), antiplatelet therapy (acetylsalicylic emacid/em) and novel oral anticoagulants such as apixaban ..."
 
Vol 10, No 1 (2014) MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT Abstract  similar documents
E. I. Trisvetova
"... pleiotropic effects due to independent metabolic activity of orotic emacid/em. ..."
 
Vol 11, No 1 (2015) CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, S. V. Utkina
"... recombinant protein comprising an amino emacid/em sequence of staphylokinase is described. The trial was held ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... -salicylic emacid/em, warfarin). Efficacy and safety of rivaroxaban is considered on the basis of the results ..."
 
Vol 13, No 5 (2017) NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE Abstract  similar documents
O. M. Drapkina, A. A. Yafarova
"... Non-alcoholic emfatty/em liver disease (NAFLD) is the most common liver disease worldwide, which ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... . The results of the study reflect the doctor’s tendency to use acetylsalicylic emacid/em for the primary prevention ..."
 
Vol 4, No 1 (2008) COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL) Abstract  similar documents
N. M. Chihladze, O. A. Sivakova, H. F. Samedova, G. N. Litonova, E. B. Yarovaya, I. E. Chazova
"... to ambulatory BP monitoring. Significant reduction in MAU level and uric emacid/em plasma concentrations were ..."
 
Vol 3, No 3 (2007) THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova
"... сни- жению бета-окисления emжирных/em emкислот/em. Недостатком данного пути является то, что митохондрии всё ..."
 
Vol 13, No 4 (2017) PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW Abstract  similar documents
I. S. Yavelov
"... and safety of prolonged use of a combination of acetylsalicylic emacid/em and blocker P2Y12 platelet receptor ..."
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... .8% of patients also received combination of clopidogrel and acetylsalicylic emacid/em, but changed medicinal products ..."
 
Vol 3, No 1 (2007) SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME Abstract  similar documents
Y. A. Vasyuk, K. G. Kulikov, O. N. Kudryakov, O. V. Krikunova, I. A. Sadulaeva
"... , происходящи- ми в митохондриях, являются: цикл трикарбоновых кис- лот, окисление emжирных/em emкислот/em, карнитиновый ..."
 
Vol 7, No 2 (2011) PATHOGENETIC MECHANISMS AND TREATMENT PRINCIPLES OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION Abstract  similar documents
N. A. Shostak, A. A. Klimenko, N. A. Demidova, I. V. Novikov
"... emжирных/em кис- лот, или кардиальный белок, связывающий свободные emжирные/em emкислоты/em. Это цитозольный белок с ..."
 
Vol 11, No 2 (2015) CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva
"... antiplatelet drugs (acetylsalicylic emacid/em and clopidogrel) and heparin. There were not any reasons ..."
 
Vol 3, No 2 (2007) OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina
"... значительно повышается содержание emжирных/em emкислот/em и их поступление в клетки миокарда, а изменения активности ..."
 
Vol 9, No 2 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... increased from 20% to 84.4%, statins - from 10% to 85.5%, β-blockers - from 20% to 91%, acetylsalicylic emacid/em ..."
 
Vol 2, No 4 (2006) THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Konstantinova, A. V. Magnitskyi, N. A. Schostak
"... and safety of fibrinolytics by their combination with acetylsalicylic emacid/em, IIb/IIIa receptor inhibitors ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... , uric emacid/em level and glucose tolerance test were performed at baseline and at the end of the study ..."
 
Vol 12, No 5 (2016) Pathogenic Mechanisms of Atrial Fibrillation in Obesity Abstract  similar documents
O. M. Drapkina, M. V. Nikolaeva
"... 11325-010- 0477-6. 13. Khawaja O, Bartz T, Ix JH, et al. Plasma free emfatty/em emacids/em and risk of atrial ..."
 
Vol 6, No 1 (2010) PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya
"... of 5’- nucleotidase, xantineoxidase and uric emacid/em level) and lipid peroxidation (superoxide dismutase ..."
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... doses of acetylsalicylic emacid/em (250 mg) and clopidogrel (600 mg). After 12-24 hours,  the patients were ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... that  risk associated with acetylsalicylic emacid/em (ASA) use in patients ≥75 years can overweigh its potential ..."
 
Vol 7, No 4 (2011) SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION Abstract  similar documents
S. V. Nedogoda
"... ; • дифференцировка адипоцитов; • окисление emжирных/em emкислот/em. Интерес к PPAR-рецепторам в последнее десятиле- тие ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... ,01) and uric emacid/em levels were registered in group C as well as tendency to lowering of total cholesterol (TC ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... effects on glucose (р0,01) and lipid blood levels. By the end of the study urine emacid/em blood level ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... ), exercise tolerance – by 6-minute walk test (6МWТ). Glucose, creatinine, urea and uric emacid/em serum levels ..."
 
1 - 100 of 487 Items 1 2 3 4 5 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)